Analyst Ratings for HOOKIPA Pharma
Portfolio Pulse from Benzinga Insights
Analysts have provided bullish ratings for HOOKIPA Pharma (NASDAQ:HOOK) in the last quarter, with an average price target of $6.12, a decrease of 23.5% from the previous average price target of $8.00.
September 27, 2023 | 4:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
HOOKIPA Pharma received bullish ratings from analysts, but the average price target has decreased by 23.5%.
While the bullish ratings indicate a positive outlook for HOOKIPA Pharma, the decrease in the average price target suggests that analysts expect a lower return from the stock in the future. This could potentially lead to a neutral impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100